Loratadine

is prescribed to treat:

• Seasonal allergies and hives • Various related conditions in the respiratory category • Associated symptoms and complications

It is an important medication that helps manage these conditions effectively.

Loratadine (Claritin) is a second-generation antihistamine used for seasonal allergic rhinitis, perennial allergic rhinitis, and chronic urticaria. Its defining property is that it treats allergy symptoms without the sedation of the older antihistamines — a distinction that matters more than most patients realise, because the sedating alternatives remain widely sold and widely used.

Mechanism of Action

Loratadine is a selective peripheral H1 receptor inverse agonist. Histamine released from mast cells during an allergic response acts on H1 receptors to produce vasodilation, increased vascular permeability, sensory nerve stimulation, and smooth muscle contraction — the itching, sneezing, rhinorrhoea, and hives that characterise allergic disease.

What separates second-generation antihistamines from first-generation agents such as diphenhydramine is central nervous system penetration. Loratadine is a substrate of P-glycoprotein, an efflux transporter at the blood-brain barrier that actively pumps it back out of the brain. Very little reaches central H1 receptors, so it does not produce the sedation, cognitive impairment, and anticholinergic effects that define the older drugs.

This is not a minor comfort difference. First-generation antihistamines impair driving performance measurably, including the morning after a night-time dose, and their anticholinergic burden is associated with confusion and falls in older adults and with cognitive decline over prolonged use. Diphenhydramine is the active ingredient in most over-the-counter sleep aids, which is how many people take it nightly for years without considering it a drug at all.

Loratadine's onset is within one to three hours and its effect lasts a full 24 hours, allowing once-daily dosing.

Clinical Use

Antihistamines work best taken regularly through an allergy season rather than reactively once symptoms have started, because they block receptors rather than reversing mediator release that has already occurred. Patients who take them only on bad days consistently get less benefit than those who dose consistently.

Among second-generation agents the differences are modest. Cetirizine is somewhat more potent and somewhat more sedating — it penetrates the CNS slightly more than loratadine — while fexofenadine is the least sedating. Individual response varies enough that a patient who does poorly on one is worth trying on another rather than concluding antihistamines do not work for them.

For allergic rhinitis specifically, intranasal corticosteroids are more effective than oral antihistamines for nasal congestion, which antihistamines address poorly. A patient whose dominant symptom is blockage rather than sneezing and itching is often better served by a nasal steroid, or by both together. The Florida allergies article covers the year-round exposure pattern here, which differs from the seasonal picture further north, and our ent team manages rhinitis that is not responding.

In chronic urticaria, second-generation antihistamines are first-line and are often used at doses above the standard label amount under specialist guidance, since higher doses improve control without the sedation that would limit a first-generation drug.

Monitoring and Follow-Up

No laboratory monitoring is required. The useful review is whether symptoms are controlled and whether the diagnosis is right.

Not all rhinitis is allergic. Non-allergic rhinitis — triggered by temperature change, humidity, odours, or irritants — produces similar congestion and rhinorrhoea but does not respond to antihistamines, because histamine is not the mediator. A patient reporting no benefit from an antihistamine may have the wrong diagnosis rather than an inadequate dose. Vasomotor rhinitis is common in this climate and is frequently mislabelled as allergy for years.

Loratadine is metabolised by CYP3A4 and CYP2D6, but because it has a wide safety margin, interactions are rarely clinically significant. This contrasts with the withdrawn antihistamines terfenadine and astemizole, whose CYP3A4-mediated accumulation caused fatal arrhythmias — the reason second-generation agents are now selected partly for a clean cardiac profile. Loratadine does not meaningfully prolong the QT interval. The MedlinePlus loratadine entry covers prescribing detail, and the NIAID allergy resource provides background on allergic disease.

Special Populations

In older adults, loratadine is a clearly preferable choice to any first-generation antihistamine, and switching a patient from nightly diphenhydramine to a non-sedating agent — or addressing the sleep problem properly — is one of the more useful deprescribing interventions available.

In pregnancy, loratadine and cetirizine are the preferred oral antihistamines, with substantial accumulated safety data. They are compatible with breastfeeding. In hepatic impairment, dose reduction is warranted since loratadine is extensively metabolised; significant kidney impairment also warrants reduced dosing. In children, loratadine is widely used with weight- and age-appropriate dosing.

Combination products pairing loratadine with pseudoephedrine are common and deserve separate consideration: the decongestant component raises blood pressure and can cause insomnia and urinary retention, and it is not appropriate for routine long-term use in patients with hypertension, heart disease, or benign prostatic hyperplasia.

Duration of treatment rarely gets discussed, and it probably should. Second-generation antihistamines are safe enough for long-term daily use that many patients simply stay on one indefinitely, which is reasonable for genuine perennial allergy but less so for someone whose original trigger was a single season years ago. Periodically stopping for a week or two to see whether symptoms return costs nothing and settles the question. Where symptoms clearly are perennial, identifying and reducing the exposure — dust mite measures, pet dander management, indoor humidity control — addresses the cause rather than the mediator, and in this climate indoor allergens often matter more than pollen.

When to Contact Your Doctor

Report allergy symptoms that are not controlled despite regular daily use, which usually means either the wrong diagnosis or the need for a nasal corticosteroid rather than a higher antihistamine dose.

Seek prompt care for difficulty breathing, wheezing, throat tightness, or swelling of the face or tongue — antihistamines do not treat anaphylaxis, and an oral tablet is not a substitute for epinephrine in a severe reaction. Report hives that persist beyond six weeks, which is chronic urticaria and warrants proper evaluation rather than indefinite self-treatment.

If you are using a combination product containing a decongestant regularly, raise it — that component has cardiovascular implications the antihistamine does not.

To review allergy symptoms that are not controlled, distinguish allergic from non-allergic rhinitis, or address chronic hives, contact us or schedule a visit.